Abstract: The administration of cytotoxic agents followed by the administration of heat shock protein 90 inhibitors, such as ansamycins, has a synergistic effect on the growth inhibition of cells. This synergy occurs at doses of each cytotoxic agent that normally only causes minimal growth inhibition of cells. Such combination therapy thus allows one to use lower doses of cytotoxic agents to avoid or reduce their respective toxicity to patients without compromising their growth inhibitory effects. Thus, these combinations can be used for the treatment of an animal, preferably a mammal, that has a cell proliferative disorder, whether the cells have wild-type Rb or are Rb deficient or Rb negative. One such method, directed to treating cell proliferative disorders includes the step of administering a therapeutic effective amount of a cytotoxic agent followed by administering a therapeutic effective amount of a heat shock protein 90 inhibitor.

Abstract: Liquid crystal polycarbonates are made by forming a reaction mixture containing (a) an activated diaryl carbonate; (b) at least two species of aromatic diols selected from among resorcinol, 4,4?-biphenol, hydroquinone, methylhydroquinone, 4,4?-dihydroxyphenylether, dihydroxynaphthalene, including in particular the 2,6, 1,5, and 2,7 isomers, 4,4?-dihydroxybenzophenone and 2,6-dihydroxyanthraquinone (anthraflavic acid); and (c) optionally bisphenol A in a maximum amount of 10 mole %; and processing the reaction mixture in a melt transesterification reaction to form a liquid crystal polycarbonate. While the product composition has the same overall characteristics as compositions made using diphenyl carbonate as the donor moiety for the carbonate linkage, they are analytically distinguishable because of limited incorporation of intermediate or end-cap residues derived from the activated diaryl carbonate.

Abstract: Compositions and a method are provided for the treatment of prostate and other endocrine tumors in mammals, including humans, by administration of an antisense oligodeoxynucleotide (ODN) which is complementary to a portion of the gene encoding IGFBP-2. Using the Shionogi tumor model in vitro and in vivo, the administration of such an ODN was shown to reduce proliferation of tumor cells, and also to delay the progression to androgen independence. Thus, treatment of prostate and other hormone-regulated cancer in mammals, including humans, and delay of the progression of prostate tumors to androgen independence is accomplished by administering to the mammal a therapeutically effective amount of an antisense oligodeoxynucleotide which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells.

Abstract: A screening method for gastritis is provided. The method involves the serological measurement of at least two of the following analytes: H,K-ATPase antibodies, Helicobacter pylori antibodies and the concentration of pepsinogen I; and the evaluation of the results in comparison with results from normal individuals. The evaluation scheme provides an initial, non-invasive identification of individuals with various forms of gastritis.

Abstract: Lenses for lamps can improve the quality of the light emitted through lens by interacting with the light bulb. Photoluminescent dyes as well as non-photoluminescent dyes may be incorporated into a polycarbonate lens in order to shift the chromaticity of the light source. Further, design features such as grooves or protrusions may be incorporated into the lens to allow light produced by the photoluminescent material to escape the lens and be added to the emitted beam to further shift the chromaticity. The emitted beam is of a legal color and intensity as defined per the SAE J578 and SAE J1383 standards. The lighting performance may also be improved in such manner as reducing discomfort glare, increasing brightness or producing a beam that enhances road visibility at night to the human eye.

Abstract: A keg is formed from (A) a shaped jacket or liner forming a container, obtained from at least two nonsymmetrical parts (1a, 1b) welded together, one of the parts containing an opening provided with a neck, and (B) a filling/tapping device (3) positioned in the neck of the opening. The part of the container with the filling/tapping opening contains a riser or peripheral skirt (13) having a height at least equal to that of the outer part of said filling/tapping device and, optionally, sufficient to contain at least one cut-out forming a handle, and while the neck of the opening contains a part (9) extending inside the lumen of the jacket and having a limited diameter at its end (10), so as to permit passage and maintenance of the tapping device (3), and containing at least one other opening (11), advantageously on the periphery of said opening for passage and maintenance of the tapping device.

Abstract: Use of a specific combination of catalysts for the first and second steps of the process for the conversion of CHP to BPA provides high yields of BPA and low impurity yields, without a requirement for the intermediate purification steps. In the first step, CHP is cleaved in the presence of a sulfated metal oxide catalyst such as sulfated Zirconia to produce phenol and acetone. In the second step, the phenol and acetone produced is reacted, preferably without intermediate purification, in the presence of a cation exchange resin catalyst that includes a cation exchange resin and a mercaptan or mercaptoalkanoic acid promoter to produce BPA.

Abstract: Cells are rendered sensitive to stimulation by introducing into a non-photoreceptor cell nucleic acid sequences encoding at least an opsin gene product, an arrestin gene product, and the alpha subunit of the heterotrimeric G protein of the Gq family. The introduced sequences are expressed by the cell to yield at least the opsin gene product, the arrestin gene product, and the alpha subunit of the heterotrimeric G protein of the Gq family. Retinal or a derivative thereof capable of bonding with the opsin gene product to form a rhodopsin is provided to the cell. The cell is then irradiated with light having a wavelength capable of converting the rhodopsin to metarhodopsin. The conversion of rhodopsin to metarhodopsin triggers a cascade of intracellular responses within the cell resulting in an increased intracellular concentration of IP3 and calcium ions.

Abstract: Multi-layer composite structures offer improved weatherability and adhesion to fiber-reinforced plastic substrates when compared to structures now available. These composites have an outer layer made from a polyacrylate, a second layer made from an acrylonitrile-styrene-acrylate rubber terpolymer; a third layer made from an ABS polymer; and optionally a fourth layer made from a polyacrylate. The layers include one or more layers having an improvement selected from among: (a) the improvement wherein the second layer is made from an acrylate-modified acrylonitrile-styrene-acrylate rubber terpolymer; (b) the improvement wherein the third layer is a modified ABS that further includes a polymer modifier that decreases the softening of the ABS on contact with styrene, and an acrylonitrile-styrene-acrylate rubber terpolymer; and (c) the improvement wherein the fourth layer is present and is a polyacrylate. This composite can be applied to a fiber-reinforced plastic substrate such as fiberglass as a coating.

Abstract: The present invention relates to a method of preparing polycarbonate comprising the steps of: (i) introducing to an extruder through a feed port a plurality of reaction components comprising a polycarbonate oligomer, an activated carbonate residue, and a transesterification catalyst, wherein the extruder comprises the feed port, a first back vent port, and a polycarbonate exit port, wherein the feed port is located between the first back vent port and the polycarbonate exit port, and wherein the resistance to flow of the reaction components from the feed port to the first back vent port is less than or equal to the resistance to flow of the reaction components from the feed port to the polycarbonate exit port; and (ii) extruding the reaction components at one or more temperatures in a range between 100° C. and 400° C., wherein during the extrusion of the reaction components, activated carbonate residue is removed through the first back vent port, thereby preparing a polycarbonate.

Abstract: The present invention relates to a method of modifying resistance of plants to diseases and/or pests by transforming the plants with a nucleic acid encoding ryegrass O-methyltransferase (OMT). The invention also relates to transformed plants, cells and seeds having increased disease and/or pest resistance by expressing rygrass O-methyltransferase (OMT).

Abstract: A thermoplastic resin molding composition comprising an alkylene aryl polyester, a core-shell impact modifier for enhancing heat resistance having a shell derived from an alkylacrylate and a rubbery acrylate core derived from an acrylate having 4 to 12 carbon atoms, an effective amount of a difunctional epoxy compound for enhancing hydrolysis resistance of the resin, and a combination of color enhancing stabilizers comprising a thioester stabilizer, a phosphite or phosphonite stabilizer and a hindered phenol stabilizer.

Abstract: Polycarbonates containing low or undetectable levels of Fries rearrangement products and comprising repeat units derived from one or more of resorcinol, hydroquinone, methylhydroquinone, bisphenol A, and 4,4?-biphenol have been prepared by the melt reaction of one or more of the aforementioned dihydroxy aromatic compounds with an ester-substituted diaryl carbonate such as bis-methyl salicyl carbonate. Low, or in many instances undetectable, levels of Fries rearrangement products are found in the product polycarbonates obtained as the combined result of a highly effective catalyst system which suppresses the Fries reaction and the use of lower melt polymerization temperatures relative to temperatures required for the analogous polymerization reactions using diphenyl carbonate.

Abstract: Alkyl ester end-capped polycarbonates have improved release properties and may be produced by a method comprising the step of combining a polycarbonate having free terminal OH groups with an end-capping reagent comprising a symmetrical activated carbonate and an alkyl ester, whereby the end-capping reagent reacts with at least some of the free hydroxyl end groups of the polycarbonate to produce an end-capped polycarbonate comprising optionally substituted aliphatic ester end groups.

Abstract: Therapeutic agents which target heat shock protein (hsp) 27 in vivo are used to provide treatment to individuals, particularly human individuals, suffering from prostate cancer and other cancers that overexpress hsp27. A therapeutic agent, for example an antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA, for example human hsp27 mRNA, is administered to an individual suffering from prostate cancer or some other cancer expressing elevated levels of hsp 27 in a therapeutically effective amount. The therapeutic agent is suitably formulated into a pharmaceutical composition which includes a pharmaceutically acceptable carrier, and packaged in dosage unit form. A preferred dosage unit form is an injectable dosage unit form.

Abstract: Fully lipid-encapsulated therapeutic agent particles of a charged therapeutic agent are prepared by combining a lipid composition containing preformed lipid vesicles, a charged therapeutic agent, and a destabilizing agent to form a mixture of preformed vesicles and therapeutic agent in a destabilizing solvent. The destabilizing solvent is effective to destabilize the membrane of the preformed lipid vesicles without disrupting the vesicles. The resulting mixture is incubated for a period of time sufficient to allow the encapsulation of the therapeutic agent within the preformed lipid vesicles. The destabilizing agent is then removed to yield fully lipid-encapsulated therapeutic agent particles. The preformed lipid vesicles comprise a charged lipid which has a charge which is opposite to the charge of the charged therapeutic agent and a modified lipid having a steric barrier moiety for control of aggregation.

Abstract: Systems and methods are provided herein for improving the selectivity and productivity of sensors via digital signal processing techniques. According to one illustrative embodiment, in an electrochemical method for monitoring of a select analyte in a mixed sample with an interfering analyte, an improvement is provided that includes applying a large amplitude potential stimulus waveform to the sample to generate a nonlinear current signal; and resolving a signal contribution from the select analyte in the generated signal by a vector projection method with an analyte vector comprising a plurality of real and imaginary parts of one or more Fourier coefficients at one or more frequencies of a reference current signal for the select analyte.

Abstract: A method is provided for reducing the color generated during production of copolycarbonate that includes quinone-type residues. The method includes the steps preparing a reaction mixture containing precursors of monomer residues, selecting a catalyst introduction strategy and adding catalysts according to the strategy. The strategy is sufficient to result in a product copolycarbonate with improved color. The method further includes the steps of introducing the reaction mixture to a series of process units and allowing the reaction mixture to polymerize thereby forming a copolycarbonate. The resulting copolycarbonate has improved color as compared to a copolycarbonate formed in a process without the steps of selecting a catalyst introduction strategy and introducing catalysts according to the selected strategy.

Abstract: A new gas discharge tube with end electrodes having chemically inert surfaces is disclosed. As the surfaces are resistant to the build-up of layers, such as oxide layers, a discharge tube according to the invention exhibits higher selectivity and better performance (e.g. higher heat-resistance and longer life-cycle time) than prior art devices, simultaneously as it offers an environmentally acceptable solution.

Abstract: The present invention provides a method of making polycarbonate oligomers, polycarbonate, molded articles formed from polycarbonate, and an apparatus for making polycarbonate. An oligomer mixture is first prepared by the steps of providing an equilibration system comprising a vessel, a reaction mixture contained within the vessel, and means for mixing the reaction mixture contained within the vessel wherein the reaction mixture comprises a melted activated diaryl carbonate composition, and a catalyst present in sufficient amount to initiate an oligomerization reaction between a dihydroxy composition and the activated diaryl carbonate to form polycarbonate oligomers.